Andrea Shiakolas, PhD
Andrea Shiakolas is a postdoctoral fellow in the Georgiev laboratory. She completed her PhD at Vanderbilt in the Georgiev laboratory in 2022. Her research focuses on developing and applying antibody discovery technologies (LIBRA-seq) against a variety of viral pathogens, including HIV, influenza, and SARS-CoV-2. She is originally from Dallas, Texas and obtained her undergraduate degree from Vanderbilt in 2015. She also worked at the Vaccine Research Center in Dr. John Mascola’s group at the NIH studying the antibody/virus co-evolution in the context of HIV. Outside of the lab, she loves playing with her puppy Doug, drinking wine, and going hiking.
I study the antibody response to a variety of pathogens including HIV, influenza, and Coronaviruses. To do this, I helped develop a technology that allows for screening of thousands of single B cells for reactivity to a variety of antigens. The technology, called LIBRA-seq, enables recovery of paired antibody sequence and antigen specificity for each single cell.